User menu

Incidence and Significance of Clostridium-difficile in Hospitalized Cancer-patients

Bibliographic reference Gerard, Mireille ; Defresne, N. ; Daneau, D. ; Vanderauwera, P. ; Delmée, Michel ; et. al. Incidence and Significance of Clostridium-difficile in Hospitalized Cancer-patients. In: European Journal of Clinical Microbiology & Infectious Diseases : an international journal on pathogenesis, diagnosis, epidemiology, therapy, and prevention of infectious diseases, Vol. 7, no. 2, p. 274-278 (1988)
Permanent URL
  1. Fekety, R. Antibiotic associated colitis. In: Mandell, G. L., Douglas, R. G., Bennett, J. E. (ed.): Principles and practice of infectious diseases. John Wiley, New York, 1985, p. 655–660.
  2. Thelestam M., Florin I., Cytopathogenic Action of Clostridium Difficile Toxins, 10.3109/15569548409097924
  3. Mulligan Maury E., Epidemiology of Clostridium difficile-Induced Intestinal Disease, 10.1093/clinids/6.supplement_1.s222
  4. Bartlett John G., Treatment of Antibiotic-Associated Pseudomembranous Colitis, 10.1093/clinids/6.supplement_1.s235
  5. Dudley, M. N., Mc Laughlin, J. C., Carrington, G., Frick, J., Nightingale, C. H., Quintiliani, R. Oral bacitracin versus vancomycin therapy forClostridium difficile induced diarrhoea. Archives of Internal Medicine 1986, 146: 1101–1104.
  6. Potvliege, C., Labbé, M., Yourassowsky, E. Gas liquid chromatography as screening test forClostridium difficile. Lancet 1981, ii: 1105.
  7. Lyerly, D. M., Phelps, C. J., Wilkins, T. D. Monoclonal and specific polyclonal antibodies for immunoassay ofClostridium difficile toxin A. Journal of Clinical Microbiology 1985, 21: 12–14.
  8. Buggy, B. P., Hawkins, C. C., Fekety, R. Effect of adding sodium taurocholate to selective media on the recovery ofClostridium difficile from environmental surfaces. Journal of Clinical Microbiology 1985, 21: 636–637.
  9. Levett, P. N., Margaritis-Bassoulis, G. Enrichment media for isolation ofClostridium difficile from faeces. European Journal of Clinical Microbiology 1986, 4: 133–136.
  10. Delmée, M., Homel, M., Wauters, G. Serogrouping ofClostridium difficile strains by slide agglutination. Journal of Clinical Microbiology 1985, 21: 323–327.
  11. Tabaqchali, S., O'Farrell, S., Holland, D., Silman, R. Method for the typing ofClostridium difficile based on polyacrylamide gel electrophoresis of35S methionine labeled proteins. Journal of Clinical Microbiology 1986, 23: 197–198.
  12. Delmée, M., Laroche, J., Avesani, V., Cornelis, G. Comparison of serogrouping and polyacrylamide gel electrophoresis for typingClostridium difficile. Journal of Clinical Microbiology 1986, 24: 991–994.
  13. Heard, R. S., Rasburn, B., Matthems, R. C., Tabaqchali, S. Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains ofClostridium difficile. Journal of Clinical Microbiology 1986, 24: 384–387.
  14. Pepersack, F., Labbé, M., Nonhoff, C., Schoutens, E. Use of screening test for toxigenicClostridium difficile in diarrheal stools. Journal of Clinical Pathology 1983, 36: 1233–1236.
  15. George, W. L., Sutter, V. L., Citron, D., Finegold, S. M. Selective and differential media for isolation ofClostridium difficile. Journal of Clinical Microbiology 1979, 9: 214–219.
  16. George, R. H., Symonds, J. M., Dimock, F., Brown, J. D., Arabi, Y., Shinagawa, N., Keighley, M. R. B., Alexander-Williams, J., Burdon, D. W. Identification ofClostridium difficile as a cause of pseudomembranous colitis. British Medical Journal 1978, i: 695.
  17. SOX HAROLD C., Diagnostic Decision: Probability Theory in the Use of Diagnostic Tests : An Introduction to Critical Study of the Literature, 10.7326/0003-4819-104-1-60
  18. Rampling, A., Warren, R. E., Bevan, P. C., Hoggarth, C. E., Swirsky, D., Hayhoe, J. F. G. Clostridium difficile in haematological malignancy. Journal of Clinical Pathology 1985, 38: 445–451.
  19. Heard S. R., O'Farrell S., Holland D., Crook S., Barnett M. J., Tabaqchali S., The Epidemiology of Clostridium difficile with Use of a Typing Scheme: Nosocomial Acquisition and Cross-Infection Among Immunocompromised Patients, 10.1093/infdis/153.1.159
  20. Pantosti, A., Gentile, G., Luzzi, I., Martino, P., Venditti, M., Serra, P., Panichi, G.: Colitis due toClostridium difficile in leukemic patients. In: Spitzy, H., Karrer, K. (ed.): Proceedings of the 13th International Congress of Chemotherapy. Vienna, 1983, SE 7.3/1: 75/25–75/29.
  21. Ainstein V. F., Bodey G. P., Relapsing Pseudomembranous Colitis Associated with Cancer Chemotherapy, 10.1093/infdis/143.6.865
  22. Milligan, D. W., Kelly, J. K. Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases. Journal of Clinical Pathology 1979, 32: 1237–1243.
  23. Bender, B. S., Laughan, B. E., Gaydo, C., Forman, M. S., Bennett, R., Greenough, W. B., Sears, S. D., Bartlett, J. G. IsClostridium difficile endemic in chronic care facilities? Lancet 1986, i: 11–13.
  24. Tabaqchali, S., O'Farrell, S., Holland, D., Silman, R. Typing scheme forClostridium difficile: its application in clinical and epidemiological studies. Lancet 1984, ii: 935–938.
  25. Richardson, S. A., Alcock, P. A., Gray, J. Clostridium difficile and its toxin in healthy neonates. British Medical Journal 1983, 287: 878.
  26. Iaconis, P. J., Rolfe, R. D. Clostridium difficile associated ileocecitis in clindamycin treated infant hamsters. Current Microbiology 1986, 13: 327–332.
  27. Aronsson B., Mollby R., Nord C.- E., Antimicrobial Agents and Clostridium difficile in Acute Enteric Disease: Epidemiological Data from Sweden, 1980-1982, 10.1093/infdis/151.3.476
  28. Aronsson B., Mollby R., Nord C. E., Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden, 10.1093/jac/14.suppl_d.85
  29. Rihn, B., Scheftel, J. M., Girardot, R., Monteil, H. A new purification procedure forClostridium difficile enterotoxin. Biochemical and Biophysical Research Communication 1984, 124: 690–695.
  30. Levett, P. N. Detection ofClostridium difficile in faeces by direct gas-liquid chromatography. Journal of Clinical Pathology 1984, 37: 117–119.